Diagnosis of AChE inhibition is typically based on clinical symptoms and confirmed by measuring AChE activity in blood samples. A significant reduction in AChE activity is indicative of exposure to AChE inhibitors. Monitoring of red blood cell AChE and plasma cholinesterase (pseudocholinesterase) activities can help assess the degree of inhibition.
